Physician profile
James Kelly
NPI 1881679553
$6,144.97
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,276 · 2020: $1,865 · 2021: $2,004.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,787.42 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $454.74 | 2019-2021 | |
| Daiichi Sankyo INC. | $411.85 | 2019 | |
| Arbor Pharmaceuticals, INC. | $322.69 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $279.06 | 2020-2021 | |
| Pfizer INC. | $251.03 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $232.82 | 2019-2021 | |
| Lilly USA, LLC | $198.46 | 2019-2021 | |
| Amgen INC. | $182.54 | 2019-2021 | |
| Abbvie INC. | $156.82 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $152.55 | 2019 | |
| Sentynl Therapeutics, INC. | $107.53 | 2019 | |
| Boston Scientific Corporation | $106.47 | 2021 | |
| Redhill Biopharma INC. | $54.83 | 2020-2021 | |
| Allergan, INC. | $52.67 | 2020-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $48.30 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.90 | 2019 | |
| Kaleo, INC. | $35.81 | 2019 | |
| Fidia Pharma USA INC. | $35.00 | 2019 | |
| Nevro Corp. | $34.65 | 2020 | |
| Vertiflex, INC. | $31.07 | 2019 | |
| Horizon Therapeutics Plc | $29.24 | 2020-2021 | |
| Pernix Therapeutics Holdings, INC. | $27.90 | 2019 | |
| Assertio Therapeutics, INC. | $25.48 | 2019 | |
| Amniox Medical, INC. | $25.18 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.45 | 2020 | |
| Epimed International, INC | $15.20 | 2019 | |
| Zimmer Biomet Holdings, INC. | $14.75 | 2019 | |
| Stimwave Technologies Incorporated | $10.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.